|
Incorporated in 1989, Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products. Information in this paragraph is copied from chittorgarh.com.
Company produces over 400 proprietary products developed from 60 enzymes. Advanced Enzyme operate in two primary business verticals namely Healthcare & Nutrition (human and animal) and Bio-Processing (food and non-food).
Company has 13 patents registered in its name and applications for registration of 4 patents are pending.
Advanced Enzyme is among top 15 companies in enzyme sales in the world and 2nd largest in India. Company has over 20 years of fermentation experience in the production of enzymes. Company offer these products to its more than 700 global customers across 50 countries around the world. Content in this paragraph is copied from chittorgarh.com.
Advanced Enzyme's R&D team consists of over 55 scientists, microbiologists, engineers, food technologists and biotechnologists. Company have four R&D facilities, of which two are located at Thane, and one each at Sinnar and Chino, California.
Competitive strengths of the company:
1. Integrated Company with presence across the Enzyme Value Chain
2. Strong R&D, enzyme development and manufacturing capabilities
3. Specialized Business Model with high entry barriers
4. Diversified Product Portfolio and Wide Customer Base, served by a Strong Sales, Marketing and Distribution network
5. Experienced Promoters and Strong Management Team
6. Financial stability and stable cash flows
The Offer consists of a Fresh Issue by the company and an Offer for Sale by the Selling Shareholders.
1. Offer for Sale
Company will not receive any proceeds from the Offer for Sale.
2. The Fresh Issue
The object of the fresh issue is to invest in Advanced Enzymes USA, the wholly owned subsidiary for repayment / pre-payment of certain loans availed by Advanced Enzymes USA; and general corporate purposes.
IPO Date | Jul 20, 2016 to Jul 22, 2016 |
Listing Date | Aug 1, 2016 |
Face Value | ₹10 per share |
Price | ₹880 to ₹896 per share |
Lot Size | 16 Shares |
Total Issue Size | 4,594,875 shares (aggregating up to ₹411.49 Cr) |
Fresh Issue | [.] shares (aggregating up to ₹50.00 Cr) |
Offer for Sale | 4,034,470 shares of ₹10 (aggregating up to ₹[.] Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
QIB Shares Offered | 918908 |
NII (HNI) Shares Offered | 686989 |
Retail Shares Offered | 1602974 |
Total Shares Offered | 3,234,059 |
The Advanced Enzyme IPO lot size is 16 shares.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 16 | ₹14,336 |
Retail (Max) | 13 | 208 | ₹186,368 |
Lot Size Calculator |
Particulars | For the year/period ended (in Rs. Million) | ||||
---|---|---|---|---|---|
31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | |
Total Assets | 4,516.50 | 4,180.92 | 4,082.76 | 3,963.47 | 3,490.09 |
Total Revenue | 2,946.37 | 2,242.69 | 2,404.81 | 2,241.15 | 1,748.78 |
Profit After Tax (PAT) | 784.35 | 501.02 | 200.86 | 492.19 | 333.36 |
[Dilip Davda] Being first mover IPO in the enzymes segment, it is catching fancy. Considering its track records and future prospects ahead, investors may consider investment for short to long term rewards. Read detail review...
The Advanced Enzyme IPO is subscribed 116.02 times on Jul 22, 2016 5:00:00 PM. The public issue subscribed 11.67 times in the retail category, 94.03 times in the QIB category, and 393.10 times in the NII category. Check Day by Day Subscription Details (Live Status)
Category | Subscription (times) |
---|---|
QIB | 94.03 |
NII | 393.10 |
Retail | 11.67 |
Employee | 1.73 |
Total | 116.02 |
Listing Date | Aug 1, 2016 |
BSE Script Code | 540025 |
NSE Symbol | ADVENZYMES |
ISIN | INE837H01012 |
IPO Price | ₹896 per share |
Price Details |
---|
IPO Price |
Open |
Low |
High |
Last Trade |
BSE |
---|
₹896.00 |
₹1,210.00 |
₹1,168.55 |
₹1,242.75 |
₹1,178.30 |
NSE |
---|
₹896.00 |
₹1,210.00 |
₹1,168.00 |
₹1,244.00 |
₹1,178.10 |
Advanced Enzyme Technologies Ltd
Sun Magnetica, 5th Floor,
Near LIC Service Road, Louiswadi,
Thane 400604, Maharashtra, India
Phone: +91-22-4170 3200
Email: prabal@adavancedenzymes.com
Website: http://www.advancedenzymes.com
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: aetl.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Advanced Enzyme IPO is a main-board IPO of 4,594,875 equity shares of the face value of ₹10 aggregating up to ₹411.49 Crores. The issue is priced at ₹880 to ₹896 per share. The minimum order quantity is 16 Shares.
The IPO opens on Jul 20, 2016, and closes on Jul 22, 2016.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Advanced Enzyme IPO opens on Jul 20, 2016 and closes on Jul 22, 2016.
Advanced Enzyme IPO lot size is 16 Shares and the minimum order quantity is .
You can apply in Advanced Enzyme IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Advanced Enzyme IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Advanced Enzyme IPO allotment status.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|